Exencial Wealth Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Buy
13,846
+314
+2% +$28K 0.04% 274
2025
Q4
$1.07M Buy
13,532
+307
+2% +$24.1K 0.03% 287
2025
Q3
$1.06M Sell
13,225
-279
-2% -$23.8K 0.03% 282
2025
Q2
$1.23M Sell
13,504
-337
-2% -$30.8K 0.04% 261
2025
Q1
$1.3M Buy
13,841
+167
+1% +$15K 0.05% 257
2024
Q4
$1.24M Sell
13,674
-145
-1% -$13.8K 0.05% 262
2024
Q3
$1.43M Sell
13,819
-297
-2% -$30.3K 0.05% 247
2024
Q2
$1.37M Buy
14,116
+420
+3% +$38.7K 0.05% 244
2024
Q1
$1.23M Sell
13,696
-1,504
-10% -$127K 0.05% 249
2023
Q4
$1.21M Buy
15,200
+201
+1% +$15.1K 0.05% 242
2023
Q3
$1.07M Sell
14,999
-1,205
-7% -$90.1K 0.05% 230
2023
Q2
$1.25M Buy
16,204
+977
+6% +$75.6K 0.06% 222
2023
Q1
$1.14M Sell
15,227
-353
-2% -$26.2K 0.06% 208
2022
Q4
$1.23M Sell
15,580
-709
-4% -$53.2K 0.07% 207
2022
Q3
$1.14M Buy
16,289
+231
+1% +$18.1K 0.07% 201
2022
Q2
$1.29M Sell
16,058
-230
-1% -$18K 0.07% 199
2022
Q1
$1.24M Sell
16,288
-84
-0.5% -$6.65K 0.06% 218
2021
Q4
$1.4M Buy
16,372
+489
+3% +$38.2K 0.07% 207
2021
Q3
$1.2M Sell
15,883
-881
-5% -$70K 0.05% 179
2021
Q2
$1.36M Sell
16,764
-1,002
-6% -$81.9K 0.07% 209
2021
Q1
$1.4M Sell
17,766
-89,375
-83% -$7.01M 0.08% 194
2020
Q4
$9.16M Buy
107,141
+3,022
+3% +$250K 0.63% 42
2020
Q3
$8.03M Buy
104,119
+9,952
+11% +$759K 0.43% 70
2020
Q2
$6.9M Buy
94,167
+8,888
+10% +$631K 0.6% 44
2020
Q1
$5.66M Buy
85,279
+2,994
+4% +$211K 1.01% 24
2019
Q4
$5.67M Buy
82,285
+3,044
+4% +$208K 0.98% 24
2019
Q3
$5.83M Buy
79,241
+1,824
+2% +$132K 1.25% 18
2019
Q2
$5.55M Sell
77,417
-2,105
-3% -$149K 1.29% 17
2019
Q1
$5.45M Sell
79,522
-2,004
-2% -$129K 1.29% 16
2018
Q4
$4.85M Sell
81,526
-429
-0.5% -$26.8K 1.3% 17
2018
Q3
$5.49M Buy
81,955
+5,986
+8% +$399K 1.28% 17
2018
Q2
$4.92M Sell
75,969
-452
-0.6% -$29.6K 1.37% 16
2018
Q1
$5.48M Sell
76,421
-3,653
-5% -$263K 1.63% 11
2017
Q4
$6.04M Buy
80,074
+2,499
+3% +$182K 1.82% 9
2017
Q3
$5.65M Buy
77,575
+19,399
+33% +$1.4M 1.86% 8
2017
Q2
$4.31M Buy
58,176
+2,799
+5% +$208K 1.77% 13
2017
Q1
$4.06M Buy
55,377
+1,516
+3% +$106K 1.76% 14
2016
Q4
$3.52M Buy
53,861
+2,941
+6% +$202K 1.49% 18
2016
Q3
$3.63M Buy
50,920
+132
+0.3% +$9.76K 1.61% 12
2016
Q2
$3.72M Sell
50,788
-163
-0.3% -$11.6K 1.68% 11
2016
Q1
$3.6M Sell
50,951
-1,538
-3% -$102K 1.7% 13
2015
Q4
$3.3M Buy
52,489
+1,302
+3% +$86.6K 1.64% 13
2015
Q3
$3.25M Buy
51,187
+3,921
+8% +$256K 1.59% 17
2015
Q2
$3.17M Buy
47,266
+639
+1% +$43.3K 2% 11
2015
Q1
$3.27M Buy
46,627
+1,756
+4% +$121K 1.37% 22
2014
Q4
$3.08M Sell
44,871
-679
-1% -$45.9K 1.36% 24
2014
Q3
$2.97M Buy
45,550
+1,094
+2% +$72.2K 1.31% 26
2014
Q2
$3.1M Sell
44,456
-947
-2% -$63.5K 1.32% 25
2014
Q1
$3.05M Sell
45,403
-395
-0.9% -$24.9K 1.28% 26
2013
Q4
$2.93M Sell
45,798
-1,955
-4% -$125K 1.33% 27
2013
Q3
$3.12M Sell
47,753
-2,476
-5% -$147K 1.46% 23
2013
Q2
$3.07M Buy
+50,229
New +$2.98M 1.52% 24

Other funds holding CL

Exencial Wealth Advisors's CL Position: Q1 2026 in Review

Exencial Wealth Advisors increased its Colgate-Palmolive (CL) stake by 2.3% in Q1 2026, buying an estimated $28K and bringing the position to 13,846 shares worth $1.18M. The position accounts for 0.04% of the portfolio, ranked #274.

Exencial Wealth Advisors first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.16M in Q4 2020. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Exencial Wealth Advisors held 13,846 shares of Colgate-Palmolive worth $1.18M as of Q1 2026.
  • Exencial Wealth Advisors bought 314 Colgate-Palmolive shares in Q1 2026, an estimated $28K.
  • Colgate-Palmolive made up 0.04% of Exencial Wealth Advisors's portfolio in Q1 2026, its #274 holding.
  • Exencial Wealth Advisors first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Exencial Wealth Advisors's Colgate-Palmolive position peaked at $9.16M in Q4 2020.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.